医药高增长轮动策略:年化收益率(6.52%)

本策略精选医药生物行业中,净利润和营收均高速增长、毛利率和净利率优秀、市盈率适中,且流通市值较小的优质股票。策略通过严格的财务指标筛选,并结合小市值偏好,力求捕捉医药行业中具备高成长潜力的投资标的,并进行短期轮动持有,以期获得超额收益。

概要

核心指标

  • 累计收益率: 10.18%
  • 年化收益率: 6.52%
  • 基准收益率: 21.51%
  • 阿尔法: -0.01
  • 夏普比率: 0.3
  • 最大回撤: 13.17%

源码

查看AI策略代码

绩效

持仓详情

当日收盘价
当日市值
浮动收益/浮动收益率
2025-08-07 甘李药业(603087.SH) 48.368603968939 1730 66 62.46 108055.8 24378.12/29.133%
2025-08-07 昊帆生物(301393.SZ) 48.364578054629 1909 66 56.33 107533.97 15205.99/16.47%
2025-08-07 大博医疗(002901.SZ) 33.655879985364 2133 71 57.4 122434.2 50646.21/70.55%
2025-08-07 兴齐眼药(300573.SZ) 55.206555555556 1700 16 61.23 104091 10239.86/10.911%
2025-08-07 宣泰医药(688247.SH) 10.793852442765 9046 186 11.95 108099.7 10458.51/10.711%
2025-08-07 特宝生物(688278.SH) 61.435341940248 1239 326 85.55 105996.45 29878.06/39.252%
2025-08-06 甘李药业(603087.SH) 48.368603968939 1830 65 64.36 117778.8 29264.25/33.062%
2025-08-06 昊帆生物(301393.SZ) 48.364578054629 1909 65 57.56 109882.04 17554.06/19.013%
2025-08-06 大博医疗(002901.SZ) 33.655879985364 2433 70 52.18 126953.94 45069.18/55.04%
2025-08-06 兴齐眼药(300573.SZ) 55.206555555556 1700 15 62.44 106148 12296.86/13.103%

交易详情

2025-08-07 宣泰医药(688247.SH) 513 12.18 6248.34 ¥5 0
2025-08-07 大博医疗(002901.SZ) -300 51.56 -15468 ¥20.47 5371.24
2025-08-07 甘李药业(603087.SH) -100 64.3 -6430 ¥11.43 1593.14
2025-07-31 宣泰医药(688247.SH) -200 12.6 -2520 ¥7.52 378.01
2025-07-31 兴齐眼药(300573.SZ) -100 64.09 -6409 ¥11.41 888.34
2025-07-24 宣泰医药(688247.SH) -500 11.8 -5900 ¥10.9 545.03
2025-07-24 大博医疗(002901.SZ) -100 43.18 -4318 ¥9.32 952.41
2025-07-17 兴齐眼药(300573.SZ) 1800 55.19 99342 ¥29.8 0
2025-07-17 大博医疗(002901.SZ) -200 41.25 -8250 ¥13.25 1518.82
2025-07-10 宣泰医药(688247.SH) -400 10.67 -4268 ¥9.27 -15.97